Co-enrollment in multiple HIV prevention trials — Experiences from the CAPRISA 004 Tenofovir gel trial
Abdool Karim
Quarraisha
author
Columbia University. Epidemiology
Kharsany
Ayesha B. M.
author
Naidoo
Kasavan
author
Yende
Nonhlanhla
author
Gengiah
Tanuja N.
author
Omar
Zaheen
author
Arulappan
Natasha
author
Mlisana
Koleka P.
author
Luthuli
Londiwe R.
author
Abdool Karim
Salim
author
Columbia University. Epidemiology
Columbia University. Epidemiology
originator
text
Articles
2011
English
Background: In settings where multiple HIV prevention trials are conducted in close proximity, trial participants may attempt to enroll in more than one trial simultaneously. Co-enrollment impacts on participant's safety and validity of trial results. We describe our experience, remedial action taken, inter-organizational collaboration and lessons learnt following the identification of co-enrolled participants. Experiences: Between February and April 2008, we identified 185 of the 398 enrolled participants as ineligible. In violation of the study protocol exclusion criteria, there was simultaneous enrollment in another HIV prevention trial (ineligible co-enrolled, n = 135), and enrollment of women who had participated in a microbicide trial within the past 12 months (ineligible not co-enrolled, n = 50). Following a complete audit of all enrolled participants, ineligible participants were discontinued via study exit visits from trial follow-up. Custom-designed education program on co-enrollment impacting on participants' safety and validity of the trial results was implemented. Shared electronic database between research units was established to enable verification of each volunteer's trial participation and to prevent future co-enrollments. Lessons learnt: Interviews with ineligible enrolled women revealed that high-quality care, financial incentives, altruistic motives, preference for sex with gel, wanting to increase their likelihood of receiving active gel, perceived low risk of discovery and peer pressure are the reasons for their enrollment in the CAPRISA 004 trial. Conclusion: Instituting education programs based on the reasons reported by women for seeking enrollment in more than one trial and using a shared central database system to identify co-enrollments have effectively prevented further co-enrollments.
Virology
Epidemiology
Contemporary Clinical Trials
32
3
333
338
2011-05
http://dx.doi.org/10.1016/j.cct.2011.01.005
http://hdl.handle.net/10022/AC:P:12484
NNC
NNC
2012-02-07 13:15:56 -0500
2012-08-02 11:43:29 -0400
6486
eng